Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note that PubMed-listed publications are automatically filled and may not all relate to the study; updated the page revision to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved the government funding lapse notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page update mainly contains minor wording and formatting changes in sections like the Brief Summary; core study information such as eligibility criteria, primary/secondary outcomes, and enrollment figures remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedMajor changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision now shows v3.0.2 (replacing v3.0.1) and the 'Back to Top' link has been removed. This is a minor maintenance update with no substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.2%

Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.